About conolidine
Andy Chevigné and his group, RTI-5152-twelve is postulated to improve the levels of opioid peptides that bind to classical opioid receptors inside the Mind, leading to heightened painkilling activity. The LIH-RTI investigation groups established a collaboration arrangement and submitted a joint patent software in December 2020.Scientific American